News

Expert explains cardiac amyloidosis

02 Nov: Expert explains cardiac amyloidosis

Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the body, including the heart, liver and kidneys. When amyloids form in the heart, the condition is referred to as cardiac amyloidosis…

Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

20 Oct: Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing hemodialysis, according to a study published online Oct. 4 in the Clinical Kidney Journal. Karlien J. ter Meulen, from Maastricht University Medical Centre in the Netherlands, and colleagues investigated the association between

Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

19 Oct: Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

Graphical abstract Geometric means (95 % confidence intervals) of (A) high-sensitivity cardiac troponin I (hs-cTnI, ng/L), a marker of cardiac injury, and (B) N-terminal pro-b-type natriuretic peptide (NT-proBNP, pg/mL), a marker of cardiac strain, according to vitamin D3 supplementation assignment at baseline (Bl) and after 3-month, 12-month, and 24-month periods. Credit: American Journal of Preventive